QuVa Pharma, Inc. Provisional
FDA Flags (6)
Class II RecallJul 2026
QuVa Pharma, Inc.
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park On
Classification: Class II
Class II RecallNov 2025
QuVa Pharma, Inc.
R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Vo
Classification: Class II
Class II RecallApr 2025
QuVa Pharma, Inc.
fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CA
Classification: Class II
Class II RecallApr 2025
QuVa Pharma, Inc.
fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FS
Classification: Class II
Class II RecallApr 2025
QuVa Pharma, Inc.
fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FS
Classification: Class II
Class III RecallOct 2022
QuVa Pharma, Inc.
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Comp
Classification: Class III